University of Oxford develops new Ebola vaccine
Scientists at the University of Oxford have developed a vaccine against the Bundibugyo strain of Ebola.
The vaccine would be assessed for safety and immune response in 50 healthy adults in the UK aged between 18 and 55.
To support the “rapid launch of the study and progression of the vaccine candidate into clinical evaluation”, some 620,000 doses of the ChAdOx1 BDBV vaccine for potential future use have been stockpiled.
Some 4,000 investigational doses have also been supplied for the Oxford trial, while researchers are also working with partners in Uganda to prepare for trials in Africa.
Volunteers will be monitored for a year, but scientists expect to know quickly whether the jab could provide people with good protection.
The new vaccine uses the same technology as the Oxford/AstraZeneca Covid-19 vaccine, meaning it could be developed in weeks.
Professor Teresa Lambe, the study’s lead scientific investigator, said, “The ongoing Bundibugyo Ebola virus outbreak continues to devastate affected communities, underlining the urgent need for effective vaccines and treatments.
“Our team has worked tirelessly with global partners to develop a candidate ChAdOx BDBV vaccine, demonstrating how collaborative partnerships can enable rapid response in the face of rapidly evolving outbreaks.
“This milestone comes after only 57 days since the World Health Organisation declared the outbreak a public health emergency of international concern.”
Dr Nicole Lurie, executive director of preparedness and response at the Coalition for Epidemic Preparedness Innovations (CEPI), said, “The deadly Bundibugyo epidemic is already the third-largest Ebola outbreak on record, and infection numbers are continuing to rise.
“The University of Oxford’s work to progress their Bundibugyo vaccine candidate, ready to enter Phase I trials in a matter of weeks, is a pivotal milestone in the response effort.
“Every step that brings a safe and effective vaccine closer helps strengthen our ability to protect vulnerable communities, save lives and bring this outbreak under control.”
(Reuters/NAN)
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette
Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices
Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”
States
Audit stolen PVCs before Osun governorship poll, Yiaga Africa tells INEC
Yiaga Africa said the disruption of PVC distribution and theft of voting materials posed a direct risk to the voting rights of affected residents in the state.
States
NEMA, UNICEF strengthen emergency response in Gombe
NEMA and UNICEF strengthened emergency response through community engagement training in Gombe.
States
My statement was misinterpreted; I told APC supporters to kill Accord Party members with votes: Fadahunsi
Mr Fadahunsi said the viral video was deliberately edited to distort his statement.
Economy
TUC backs private sector equity in refineries, rejects outright sale
Mr Osifo said the government should reduce its equity to 49 per cent and allow credible private investors with technical expertise to hold the remaining 51 per cent.
Africa
Obasanjo urges Africa to develop its own democracy model
He said the democratic model adopted by African countries lacked sufficient African context and often failed to meet the continent’s needs.
Economy
Stock market reverses gains as investors lose N1.17 trillion amid sell-offs
Market capitalisation fell by 0.73 per cent from N160.421 trillion to N159.255 trillion, while the All-Share Index (ASI) shed 1,806.18 points to close at 246,723.57.
